Business Context and Reporting Period
Company: Innovative Industrial Properties, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 31, 2018
Event: Acquisition of a property in Holliston, Massachusetts, and entry into a triple-net lease and development agreement with PharmaCannis Massachusetts Inc. (a subsidiary of PharmaCann LLC).
Key Financial Metrics and Transaction Details
- Acquisition Cost: $3.0 million for the property located at Lot 1, Hopping Brook Road, Holliston, MA.
- Construction Funding: Up to $15.5 million to be provided by the Landlord to the Tenant for development.
- Total Expected Investment: $18.5 million (assuming full funding of construction).
- Development Scope: Approximately 32,000 sq. ft. greenhouse facility and 26,000 sq. ft. industrial facility.
- Lease Term: 15.25 years, with two options to extend for five-year periods each.
- Base Rent: Initial annualized base rent of $2,682,500 (payable monthly).
- Rent Yield: 14.5% of the total investment (purchase price + construction funding).
- Rent Abatement: Base rent is abated for the first six months of the lease term.
- Rent Escalation: Annual increases of 3.25%.
- Property Management Fee: 1.5% of the then-current Base Rent.
- Security Deposit: Initial deposit of $108,750; full deposit of $670,625 required within 15 months of lease commencement.
Material Changes and Transaction Structure
The filing reports the completion of an asset acquisition and the execution of a material definitive agreement. The transaction structure involves a "build-to-suit" model where the Company acquires the land and funds the construction, while the Tenant (PharmaCannis) is responsible for development execution and assumes all operating costs (taxes, insurance, maintenance) under a triple-net lease. The Tenant has a purchase option at the end of the initial lease term based on the greater of fair market value, a capitalization rate of 8%, or the Company's total investment indexed to inflation.
Outlook, Risks, and Contingencies
- Development Risks: The Company highlighted risks associated with ground-up construction, including cost overruns, permitting delays, labor stoppages, and environmental issues, which could adversely impact financial condition and deferred revenue.
- Cannabis Industry Risks: The filing notes significant risks related to federal enforcement of cannabis laws. While the lease permits medical-use operations, it does not prohibit adult-use operations if legalized under state law (e.g., Massachusetts adult-use sales expected in 2018).
- Tenant Performance: Risks exist regarding the Tenant's ability to complete development on budget and schedule, which could affect their ability to make lease payments.
- Guaranty: Any entity affiliated with the Tenant operating in the cannabis industry must provide a full guaranty of the Tenant's lease obligations.
Investor Verification Checklist
- Verify the status of permitting and zoning approvals for the 58,000 sq. ft. cannabis facility in Holliston, MA.
- Confirm the timeline for the commencement of construction and the schedule for the $15.5 million construction funding draws.
- Review the financial health and operational track record of PharmaCann LLC and its subsidiary, PharmaCannis Massachusetts Inc.
- Assess the impact of potential adult-use cannabis legalization in Massachusetts on the Company's risk profile and federal compliance status.
- Monitor the execution of the security deposit increases tied to construction funding draws.